VCEL
Vericel Corp
Halal Rating :
Last Price
$59.07
Last updated:
Market Cap
-
7D Change
-0.92%
1 Year Change
40.54%
Company Overview
Industries
Exchange
Next Earnings Date
Vericel Corporation is a commercial-stage biopharmaceutical company focused on developing and manufacturing advanced cell therapies for the sports medicine and severe burn care markets. The company's product portfolio includes MACI (autologous cultured chondrocytes on porcine collagen membrane) for knee cartilage repair and Epicel (cultured epidermal autografts) for treating severe burns.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $57.91m | $60.52m | - | $154000.0 | 0.00% | 0.25% |
| June 30, 2024 | $52.66m | $58.85m | - | $153000.0 | 0.00% | 0.26% |
| March 31, 2024 | $51.28m | $56.9m | - | $153000.0 | 0.00% | 0.27% |
Company Impact
Help us evaluate Vericel Corp's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.